Table 1.
Demographics and clinical and laboratory data at admission in the patients with HFRS of different clinical types.
| Variables | Mild (n = 72) | Severe (n = 74) | P-value |
|---|---|---|---|
| Male, n (%) | 49 (68.1) | 60 (81.1) | 0.070 |
| Age, years | 43.79 ± 16.71 | 46.13 ± 15.46 | 0.380 |
| Max temperature, °C ± | 38.9 ± 0.77 | 39.05 ± 0.73 | 0.280 |
| Admitted days after fever, days | 5.92 ± 4.08 | 6.14 ± 2.94 | 0.711 |
| SBP, mmHg | 120 (17.5) | 118 (23.5) | 0.638 |
| DBP, mmHg | 79 (14) | 78 (19.25) | 0.508 |
| Smoking, n (%) | 32 (44.4) | 39 (52.7) | 0.318 |
| Alcohol consumption, n (%) | 29 (40.3) | 37 (50) | 0.238 |
| COMORBIDITY | |||
| Hypertension, n (%) | 11 (15.3) | 12 (16.2) | 0.876 |
| Diabetes mellitus, n (%) | 6 (8.3) | 1 (1.4) | 0.113 |
| Coronary heart disease, n (%) | 3 (4.2) | 2 (2.7) | 0.975 |
| HFRS-RELATED COMPLICATION | |||
| Hemorrhage, n (%) | 31 (43.1) | 52 (70.3) | 0.001 |
| Bacterial infection, n (%) | 42 (58.3) | 45 (60.8) | 0.760 |
| Hepatic injury, n (%) | 32 (44.4) | 46 (62.2) | 0.032 |
| Sepsis, n (%) | 0 | 6 (8.1) | 0.040 |
| MODS, n (%) | 0 | 8 (10.8) | 0.012 |
| Arrhythmia, n (%) | 2 (2.8) | 7 (9.5) | 0.182 |
| Blood transfusion, n (%) | 11 (15.3) | 44 (59.5) | <0.001 |
| CRRT, n (%) | 0 | 39 (52.7) | <0.001 |
| Hospital stay, days | 10 (1-27) | 13 (3–47) | <0.001 |
| Number of deaths, n (%) | 1 (1.4) | 12 (16.2) | 0.002 |
| PARAMETERS | |||
| WBC, × 109 cells/L | 8.07 ± 6.70 | 11.81 ± 11.23 | < 0.001 |
| PLT, × 109 cells/L | 100.82 ± 79.83 | 66.74 ± 70.85 | 0.007 |
| Neutrophils percentage, (%) | 65.60 ± 16.29 | 69.09 ± 13.76 | 0.165 |
| Lymphocytes percentage, (%) | 23.99 ± 12.98 | 20.76 ± 11.13 | 0.109 |
| PCT, (ng/ml) | 0.81 (0.03-23.39) | 2.74 (0.08–62.91) | <0.001 |
| Lg PCT | −0.11 ± 0.66 | 0.44 ± 0.62 | <0.001 |
SBP, systolic blood pressure; DBP, diastolic blood pressure; MODS, multiple organ dysfunction syndrome; CRRT, continuous renal replacement therapy; WBC, white blood cell count; PLT, platelet; Lg PCT, procalcitonin after log10 transformation.